PGIM Jennison Health Sciences Fund - Class A (PHLAX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD

40.38

-0.83 (-2.01%)

At close: Nov 12, 2026

Fund Assets	1.48B
Expense Ratio	1.097%
Min. Investment	$1,000
Turnover	81.00%
Dividend (ttm)	0.05
Dividend Yield	0.11%
Dividend Growth	-84.96%
Payout Frequency	Annual
Ex-Dividend Date	Dec 19, 2025

Previous Close	41.21
YTD Return	16.25%
1-Year Return	23.38%
5-Year Return	65.18%
52-Week Low	32.05
52-Week High	41.48
Beta (5Y)	0.93
Holdings	58
Inception Date	Jun 30, 1999

About PHLAX

PGIM Jennison Health Sciences Fund Class A is a mutual fund focused on long-term capital appreciation by investing primarily in equity and equity-related securities of U.S. companies within the healthcare sector. The fund targets firms engaged in pharmaceuticals, biotechnology, medical equipment, hospitals, nursing care, and health insurance carriers. With assets totaling approximately $1.68 billion and an expense ratio of about 1.13%, it offers exposure to a diversified portfolio of around 46 holdings, including prominent healthcare companies such as Eli Lilly, UnitedHealth Group, and Bristol-Myers Squibb. Since its inception in 1999, the fund has sought to leverage healthcare innovation and growth trends to deliver value, making it a specialized vehicle within the health sciences investment space. The fund pays dividends annually and maintains a focus on large growth companies in the health sector.

Fund Family PGIM

Category Health

Performance Rating High

Risk Rating Average

Stock Exchange Nasdaq

Ticker Symbol PHLAX

Share Class Class A

Index S&P Composite 1500 Health Care TR

Performance

PHLAX had a total return of 23.38% in the past year, including dividends. Since the fund's inception, the average annual return has been 14.51%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
PHLQX	Class R6	0.80%
PHSZX	Class Z	0.88%
PJHRX	Class R	1.48%
PHLCX	Class C	1.97%

Top 10 Holdings

56.45% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	17.76%
Merck & Co., Inc.	MRK	7.25%
Thermo Fisher Scientific Inc.	TMO	5.56%
UnitedHealth Group Incorporated	UNH	5.53%
Vertex Pharmaceuticals Incorporated	VRTX	4.19%
Danaher Corporation	DHR	3.64%
argenx SE	ARGX	3.43%
Prudential Govt Money Mkt Fd	n/a	3.40%
CVS Health Corporation	CVS	3.05%
Roivant Sciences Ltd.	ROIV	2.63%

View More Holdings

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 19, 2025	$5.04682	Dec 19, 2025
Dec 20, 2024	$5.31325	Dec 20, 2024
Dec 20, 2023	$1.91322	Dec 20, 2023
Dec 20, 2022	$0.61624	Dec 20, 2022
Dec 20, 2021	$14.02528	Dec 20, 2021
Dec 20, 2019	$1.43164	Dec 20, 2019

Full Dividend History